WOD Retail Solutions Inc. (fka WODI)

[jmhollen]

Some previous DD from SI:

January 16, 2003
MAMMATECH CORP (MAMH.OB)
Quarterly Report (SEC form 10-Q)
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND
RESULTS OF OPERATION FOR MAMMATECH CORPORATION

Results for the first quarter of Fiscal 2002 were encouraging. Sales increased by 37% from
the previous quarter and 102% compared to the first quarter of 2001. Operating costs of
$96,526 represent a 2.5% increase relative to the prior year quarter. The net income of $41,159
for the quarter contrasts with losses for both the previous quarter and the first quarter of 2001.
A portion of this figure represents reimbursement on a new SBIR grant (see below), but $15,271
is actual operation income resulting from sales and training revenues.

During the quarter, the Company participated in the opening of a MammaCare Training Center in
Frankfurt, Germany. This facility is located in the Gynecology Department of Wolfgang Goethe
University Medical School and will teach MammaCare Breast self-examination to patients in
addition to training European professionals in the skills of MammaCare Clinical Breast
examination.

The Company also started work on a Phase I SBIR project aimed at extending the MammaCare
Clinical Breast Examination technology to disabled women who have difficulty assuming the
optimal positions for this procedure. Early activities have centered on acquiring and modifying
special equipment to assist in the training process.

Finally, the Company launched a new model for providing MammaCare training at the
institutional level. A prototype agreement creates a MammaCare Training Center at an
institution dedicated to training healthcare professionals. The

first such agreement has been concluded with the University of Florida College of Nursing and
others are in various stages of negotiation. The intent is to expand the availability of the high
level of professional training now available only at MammaCare headquarters and George
Washington University. There can be no assurance, however, that this strategy will succeed or
that substantial revenue will result.

With the exception of a small note to an unaffiliated supplier for a manufacturing facility, the
Company remains debt free and has no immediate liquidity problems. The Company
continues to seek a larger partner in the healthcare industry.